Gleevec is a prescription drug used to treat certain cancers. It works by inhibiting a protein called bcr-abl that drives uncontrolled cell growth. This protein is the result of a genetic abnormality known as the philadelphia chromosome. By blocking its activity Gleevec reduces the signaling that promotes cancer cell proliferation. The medication is absorbed orally and reaches target cells where it binds to the kinase domain of bcr-abl. Binding prevents the phosphorylation of downstream substrates which leads to cell death in malignant cells. Overall Gleevec provides a targeted therapeutic effect that improves outcomes for patients with philadelphia chromosome positive leukemias.

Gleevec is a prescription drug used to treat certain types of chronic myeloid leukemia. It functions by blocking the abnormal bcr-abl protein that drives uncontrolled cell growth. By inhibiting this kinase the drug restores normal cell cycle regulation. This inhibition leads to reduced proliferation of leukemic cells and improved patient outcomes. The medication is classified as a tyrosine kinase inhibitor because it targets specific enzyme activity. Its selective binding to the abnormal protein confers high specificity and minimal interaction with healthy tissues. The drug is administered orally and exerts systemic effects throughout the bloodstream. Overall the pharmacology of Gleevec enables precise targeting of a molecular defect underlying a malignant disease.

Gleevec may cause swelling in the hands and feet as a common side effect. Nausea and vomiting are frequently reported gastrointestinal symptoms. Cardiovascular effects such as fluid retention and low blood pressure can occur. Skin reactions like rash and itching are possible dermatologic side effects. Liver function abnormalities may be observed during treatment monitoring. Fatigue and headache are additional symptoms that some patients experience.

Gleevec can cause nausea or mild stomach discomfort in some individuals. Fatigue is a commonly reported side effect that may affect daily energy levels. Muscle cramps or joint pain have been observed in a portion of users. Skin reactions such as rash or itching may occur without warning. Headaches are frequently listed among the reported symptoms. Swelling of the hands or feet can develop as a result of fluid retention. Changes in appetite or weight loss have been documented in clinical studies.